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Early Maladjustment Schemas in Individuals 
with and without Type 2 Diabetes Mellitus 
 Fazlolah Mirdrikvand1, Mohammad Ali Sepahvandi1, Siamak Khodarahimi2*, 
Simin Gholamrezaei1, Mojtaba Rahmian Bougar3, Pejman Shafikhani3 
 
1Lorestan University; Department of Psychology; Khorramabad; Iran  
2Eghlid Branch, Islamic Azad University; Iran  
3Shiraz University of Medical Sciences; Shiraz; Iran  
Abstract Objective. This study explored Early Maladjustment Schemas (EMSs) among 
individuals with and without type 2 diabetes mellitus and examined potential moderating 
roles for gender, level of education, and occupation.  
Methods. The sample included 371 adult participants (120 patients with diabetes and 
251 individuals without diabetes), from Shiraz City, Fars province; Iran. The Young 
Schema Questionnaire-Short Form (YSQ-SF) was used to assess early maladjustment 
schemas.  
Results. Findings showed that patients with type 2 diabetes had significantly higher 
scores than controls on a number of EMSs, including abandonment, failure, 
vulnerability, enmeshment, self-sacrifice, entitlement, and insufficient self-control 
schemas as well as the over-vigilance and inhibition schematic domains. However, 
results did not support roles for gender, the level of education, and occupation on any of 
EMSs and schematic domains.  
Conclusions. Medical and health professionals may find these results helpful for 
assessment, treatment, and prevention goals in patients with type 2 diabetes. 
Keywords  Type 2 Diabetes Mellitus; Normal individuals; Early Maladjustment Schemas; 
Schematic Domains. 
Highlights  Patients with type 2 diabetes mellitus have significantly higher scores in abandonment, 
failure, vulnerability, enmeshment, self-sacrifice, entitlement and insufficient self control 
schemas. 
 Patients with type 2 diabetes mellitus have significantly higher scores in over-vigilance 
and inhibition schematic domains. 
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Introduction 
Diabetes mellitus is a major health problem, 
particularly in the Middle East (1). The prevalence of 
diabetes has increased rapidly in Iran since the first 
national comprehensive survey in 1999 to the present (2). 
For example, trend analyses show a 35% increase in the 
prevalence rate of diabetes among Iranian adults from 
2005 to 2011 (3). Moreover among all cases of diabetes, 
the proportion of type 2 diabetes mellitus (T2DM) was 
85.5% in the country in 2015–2016 (4). Studies have 
demonstrated a higher prevalence in females (12.86%) 
than males (9.90%). From a psychopathological 
perspective, research has shown that psychological 
distress, agitation, and mental preoccupation with disease 
are common in patients with diabetes mellitus (5). Thus, 
diabetes-related distress is an indicator of health-related 
quality of life in patients with this disease, as it relates to 
how patients may handle their negative emotions toward 
the diagnosis and complications of diabetes, how to 
achieve good self-management, and how to access 
appropriate social support for an effective outcome (6, 7).  
Chronic distress can predispose diabetic patients for 
the development of various psychopathologcial and 
psychological disorders, with many studies demonstrating 
that anxiety disorders and depression are the most 
frequent psychiatric comorbid conditions in patients with 
type 2 diabetes (8-11). In addition, investigations have 
affirmed that cognitive dysfunction as a form of 
psychopathology is frequent among patients with type 2 
diabetes, and this dysfunction can influence self-care and 
general quality of life (12-14). Munshi (2017) showed 
that cognitive dysfunctions in patients with type 2 
diabetes can vary on a spectrum from a mild impairment 
(i.e., cognitive dysfunction without difficulty performing 
daily activities) to severe dysfunction (i.e., dementia).  
In general, “schema” is an indicator of both functional 
and dysfunctional cognitive functioning. Schemas are 
considered the basis for perception, classification, 
viewing, differentiating, and encoding of different stimuli 
encountered by individuals during the course of their 
lifetime (15). In the fields of cognitive psychology, 
cognitive development, self-psychology, and attachment 
theory, the concept of schema is used to understand and 
explain the developmental nature of psychopathology 
among patients with mental disorders or physical diseases 
(16). Segal (1988) suggested that each schema shows 
some ingredients of past reactions and experiences, which 
shape a fairly cohesive entity of knowledge and directs 
the consecutive perception and appraisals in everyday life 
(17). Young (1990) refers to schema as "templates for the 
processing of later experience". The development of early 
maladaptive schemas (EMSs) may lead to dysfunctional 
and self-preserving mechanisms throughout one’s life-
time, which in turn lead an individual to perform and 
behave in maladaptive ways involving distorting reality, 
stress and pessimism.  
Research has further demonstrated that dysfunctional 
cognitive schemas have influential roles on the 
development of psychosomatic disorders (18, 19). For 
instance, Dattilio (2010) conceptualized that generalized/ 
superordinate level of cognitive schemas are resistant to 
change and that they have a powerful influence over 
thoughts, affects, behaviors, and even physical and 
physiologic processes in patients with physical diseases. 
Since both the immune system and central nervous system 
have the capacity to learn and form memory, Dattilio 
(2010)  suggested that a form of storage for cognitive 
schema is located not only in the brain but also in cells 
that are distributed throughout the entire body (15). 
According to the mind theory as the function of brain-cell 
connection (15), it appears that cognitive schemas can 
influence the whole-body performance in patients with 
psychosomatic and chronic diseases. In line with the 
aforesaid conceptualizations, several studies have 
highlighted dysfunctional schema in patient with physical 
diseases. Ameri and colleagues (2014) indicated a 
significant difference between the mean scores of normal 
individuals and asthmatic patients on all major domains of 
EMSs, excepting other-directedness (20). Gojani and 
colleagues (2017) showed that schema-based therapy can 
reduce defeated schema, dependence vs. incompetence 
schema, devotion schema, merit schema, stubbornly 
criteria schema, and restraint/inadequate self-discipline 
schema in patients with psoriasis (21).  
However, there is still a lack of evidence about 
maladaptive schemas in patients with type 2 diabetes. 
Therefore, this study examined the Early Maladjustment 
Schemas (EMSs) among individuals with and without 
type 2 diabetes mellitus and investigated potential roles 
for gender, the level of education, and occupation 
variables. 
The study design 
Based on an integrative approach for behavioral and 
psychosocial interventions in diabetes (22), motivators, 
inhibitors/facilitators, intentions, and triggers are 
considered as four factors which influences the outcome 
of therapeutic interventions in patients. Motivators consist 
of needs and outcome expectances, and predispose 
patients to action and adherence to the treatment process. 
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Inhibitors/facilitators represent either barriers or resources 
for accomplishment of the treatment process. Intentions 
are the external or inner cause for behavior change toward 
the therapy goals. Triggers are the factors that change a 
personal readiness into an action state (22). The present 
study assumes that these four factors function in the 
maladaptive schemas in disease-stress conceptualizations 
and are important to an integrative approach for 
biopsychological interventions in diabetes (5-7, 15-19, 
22). This study further suggests that patients with diabetes 
commonly have a multifaceted set of repetitive thoughts 
and feelings about disease; worries about access to care; 
concerns about nutrition and diet, physical action, drugs 
and medications; psychological insulin confrontation; and 
not receiving adequate support from family members and 
others. Thus, the psychological distress response to 
diabetes may become a significant contributor to 
undesirable disease course, prognosis, and outcome, due 
to its relationship to both reduced metabolic control and 
impairment of the quality of life. Therefore, a careful 
assessment of cognitive schematic dysfunctions in 
patients with type 2 diabetes is essential for addressing 
psychological distress, and may assist in increasing 
treatment efficacy (23). Finally, this study suggests that 
negative experiences and psychological distress due to 
type 2 diabetes as a chronic disease can provoke some 
EMSs, which could influence treatment management in 
these patients. The present study hypothesizes that 
individuals with and without type 2 diabetes will differ in 
EMSs, with possible moderating effects from gender, the 
level of education, and job variables.  
Materials and Methods 
Participants  
The study sample consisted of 371 adult participants 
(females with diabetes =96, males with diabetes =24, 
females without diabetes=103, and males without 
diabetes=148), from Shiraz City, Fars province, Iran. 
Mean ages and standard deviation for individuals with 
and without diabetes were 51.4 (SD=6.05) and 48.4 
(SD=5.14) respectively. The level of education ranged 
from less than diploma (N=100), to diploma (N=140), 
skill degree (N=43), bachelor degree (N=73), and master 
or doctorate (N=15). All participants were Muslim. 
Participants were enlisted using a non-random purposeful 
sampling strategy among over 30 year-old adults from 
outpatient clinics in Shiraz City. Inclusion criteria for 
patients with type 2 diabetes were: 1- over 30 years-old, 
2- on diabetes care for more than six months, 3- meeting 
all clinical criteria for type 2 diabetes, 4- free of clinical 
psychological or psychiatric co-morbidities that might 
influence cognitive function, and 5- proficiency in the 
Persian language. Inclusion criteria for individuals in the 
control group were: 1- over 30 years-old, 2- free of 
serious health complications during the past year, 3- 
having no history of diabetes among his/her close 
relatives, 4- having no PPG, 5- free of cardiovascular 
disease, hypertension, or other chronic diseases, 6- having 
a BMI lower than 25, 7- being a non-smoker and free of 
drug abuse, 8- having no clinical psychological or 
psychiatric co-morbidities that might affect cognitive 
function, and 9- proficiency in the Persian language. Each 
participant was addressed individually and completed the 
study’s informed approval prior to contribution.  
Materials  
The Young Schema Questionnaire-Short Form (YSQ-
SF; Young, 1998) was used to assess EMSs. The YSQ–
SF is a 75-item self-rating questionnaire which measures 
the early maladjustment schemas. In this survey, 
participants respond to items on a Likert-type scale from 
1 (completely untrue of me) to 6 (describes me perfectly). 
The YSQ–SF contains 15 subscales: Emotional 
Deprivation (e.g., In general, people have not been there 
to give me warmth, holding, and affection), Abandonment 
(e.g., I worry that people I feel close to will leave me or 
abandon me), Mistrust/Abuse (e.g., I feel that people will 
take advantage of me), Social Isolation (e.g., I don't 
belong; I'm a loner), Defectiveness (e.g.,. I feel that I'm 
not lovable), Failure (e.g., I'm not as talented as most 
people are at their work), Vulnerability (e.g., I worry 
about being attacked), Dependence (e.g., I lack common 
sense), Subjugation (e.g., In relationships, I let the other 
person have the upper hand), Enmeshment (e.g., I often 
feel that I do not have a separate identity from my 
parent(s) or partner), Emotional Inhibition (e.g., I find it 
hard to be warm and spontaneous), Self-Sacrifice (e.g., I 
am a good person because I think of others more than of 
myself), Entitlement (e.g., I hate to be constrained or kept 
from doing what I want), Unrelenting Standards (e.g., I 
must meet all my responsibilities), and Insufficient Self 
Control (e.g., I have rarely been able to stick to my 
resolutions) (24).  
These 15 subscales fall into five domains including: 
(a) Disconnection and Rejection, (b) Impaired Autonomy 
and Performance, (c) Impaired Limits, (d) Other-
Directedness, and (e) Entitlement and Insufficient Self-
Control. The first domain represents lack of sufficient 
love and attention, supervision, and direction for the 
individual by his/her family during childhood. This 
domain assesses deterioration of the individual’s self-
Fazlolah Mirdrikvand et al. 
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confidence and self-esteem by his/her parents in 
childhood. The second domain represents leniency, 
including a lack of regulations and boundaries in 
childhood. The third domain represents pathological or 
non-ordinary tendencies between children and families in 
childhood. The fourth domain is an indication of low 
power and poor self-control schemas. The fifth domain 
represents the role of non-sympathetic and insensitive 
parents who naturally valued self-control and self-denial 
in their children (18).  
The validity and reliability of the YSQ-SF have been 
affirmed in clinical and non-clinical studies (24-26). 
Research with the Persian language version of the YSQ-
SF has demonstrated its validity and reliability in Iran 
(27). Reliability analysis of the YSQ-SF using Cronbach’s 
alpha indicates internal consistency of the domains, 
Disconnection and Rejection (DR), Impaired Autonomy 
and Performance (IAP), Impaired Limits (IL), Other-
Directedness (OD), and Over-Vigilance and Inhibition 
(OVI) domains, found to be .90, .88, .92, .90, .94 and .90 
respectively. 
Results 
To evaluate differences in EMSs across diabetic and 
non-diabetic groups, a multivariate analysis of covariance 
(MANCOVA) was performed, with group status, gender, 
the level of education, and job type entered as fixed 
independent variables and maladjustment schemas (i.e. 15 
schemas and 5 schematic domains) as dependent 
variables. This analysis showed differences based on 
group status, Wilks’k = .712; F(15, 352) = 9.47; p <.0001) 
regarding abandonment, failure, vulnerability, 
enmeshment, self-sacrifice, entitlement and insufficient 
self control schemas; and over-vigilance and inhibition 
schematic domains. Tests of between-subjects effects 
using LSD posthoc analysis showed that patients with 
type 2 diabetes had significantly higher scores in the 
aforementioned 7 maladjustment schemas as well as the 
over-vigilance and inhibition schematic domains than 
non-diabetic controls (Table 1). However, this analysis 
did not support moderating roles for gender, Wilks’k = 
.975; F(15, 352) = .601; p <.87; the level of education, 
Wilks’k = .968; F(15, 352) = .986; p <.889; and 
occupation, Wilks’k = .964; F(15, 352) = .887; p <.57. 
Discussions 
Significant group differences for a number of EMSs 
were found, specifically regarding abandonment, failure, 
vulnerability, enmeshment, self-sacrifice, entitlement, 
insufficient self control schemas, and over-vigilance and 
inhibition schematic domain were found in this sample. 
But no differences between clinical and control groups 
were found on the other subscales: emotional deprivation, 
mistrust/abuse, social isolation, defectiveness, 
dependence, subjugation, emotional inhibition, 
unrelenting standards, disconnection and rejection, 
impaired autonomy and performance, impaired limits, 
emotional inhibition and unrelenting standards schematic 
domains in this sample. In general, these results are 
consistent with predictions of a number of developmental 
psychopathology (15-19, 28-31), as well as with the 
assumptions of the disease-stress model and the 
integrative approach for behavioral and psychosocial 
interventions in diabetes (5-7, 15-19, 22) which suggest 
schema differences associated with mental or physical 
disease states.  
These results are also consistent with previous 
research which has supported the roles of maladaptive 
schemas, cognitive dysfunctions, and a role for schema 
therapy regarding the occurrence of or treatment for 
chronic diseases. For example, Gojani and colleagues 
reported that schema-based therapy can significantly 
reduce EMSs in patients with psoriasis (21). Farrell and 
colleagues showed a positive relationship between 
cognitive distortions and perception of stress in children 
and adolescents who were diagnosed with Type I diabetes 
(32). Smith and colleagues demonstrated a positive 
correlation between cognitive dysfunctions and disability 
scores in patient with chronic low back pain and further 
that pain-related and general cognitive dysfunctions  
significantly correlated with depressed mood in patients 
with rheumatoid arthritis (33-35). Bums and colleagues 
recognized the influence of cognitive dysfunctions on the 
treatment of chronic pain (34). Finally, Santos Ribas and 
colleagues reported a significant positive association 
between migraines and hypervigilance and inhibition, 
unrelenting standards, and self-punishment maladaptive 
schemas (36). In line with previous research supporting 
roles for psychological distress, cognitive dysfunction, 
and maladaptive schemas on development and treatment 
of diabetes and other psychosomatic diseases (6-12, 14, 
20-23), the present findings verify the influence of some 
EMS’s in patients with type 2 diabetes. The study further 
suggests that a similar predisposition to engage in 
maladaptive cognitive schemas may influence health-
related behaviors in patients with type 2 diabetes. 
Therefore, these findings highlight how psychological 
vulnerability and poor self-management of negative 
emotions are associated with EMSs which may 
predispose an individual for the progression or 
maintenance of type 2 diabetes in his/her later life. Thus, 
EMSs may play an important role in the establishment 
and maintenance of psychological distress in patients with 
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Type II diabetes. The underlying mechanism of EMSs is 
assumed to occur at an autonomous level, developed as a 
result of mental processing of childhood experiences, with 
individuals later engaging in distorted thought processes 
testing while attempting to establish a coherent image of 
the chronic health threat. Patients' mental representations 
of disease are therefore based on distinct maladaptive 
schemas which in turn may affect the way they cope with 
the disease, as seen in the over-vigilance and inhibition 
schematic domains of patients with type 2 diabetes. 
 
Conclusions 
This study builds upon current thinking within 
medical psychology by demonstrating higher levels of 
some EMSs in patients with type 2 diabetes mellitus; at 
the same time, no differences occurred due to gender, the 
level of education, or occupation of the patients. Medical 
and health professionals may utilize these findings to 
assist in developing an integrated biopsychosocial 
approach for the assessment, treatment, and prevention 
goals in patients with type 2 diabetes. Likewise, these 
results may be valuable for instructional and educational 
purposes by recognizing possible roles of maladjustment 
schemas in the rehabilitation of patients with diabetes. 
The study is limited by the use of a single self-rating 
inventory in individuals with and without type 2 diabetes. 
Future investigation may benefit from both quantitative 
and qualitative procedures to explore how early 
psychological experiences and dysfunctional emotions-
regulation may influence the nature and severity of EMSs 
in patients with type 2 diabetes. 
Table 1. Early Maladjustment Schemas in Individuals with and without Type 2 Diabetes Mellitus 
 
 
Early Maladjustment Schemas 
                                           Groups  
 
F                   p 
 
  Type 2 Diabetes          Control Group       Total 
M  SD M SD M SD  
 
Emotional deprivation 9.55 7.04 7.88 5.60 8.42 6.15 1.64 .20 
Abandonment 13.49 7.18 9.78 6.79 10.98 7.12 11.72 .001 
Mistrust/Abuse 6.83 4.07 6.35 3.82 6.67 3.91 1.75 .18 
Social isolation 6.90 3.83 6.45 4.27 6.76 4.13 1.49 .22 
Defectiveness 6.74 2.65 5.27 3.24 6.10 3.07 3.10 .07 
Failure 10.72 5.68 7.84 5.07 8.77 5.43 10.11 .002 
Dependence 6.90 4.36 6.65 4.09 6.82 4.18 1.80 .18 
Vulnerability 10.95 5.55 7.58 5.05 8.67 5.44 20.56 .0001 
Enmeshment 6.85 3.76 5.70 3.67 6.42 3.71 6.70 .01 
Subjugation 6.69 4.55 6.58 3.99 6.78 4.18 1.68 .19 
Self-sacrifice 12.25 7.42 10.06 7.39 10.77 7.46 3.48 .05 
Emotional inhibition 7.78 4.79 7.43 5.39 7.67 5.20 1.01 .31 
Unrelenting standards 16.94 3.22 15.16 3.75 16.09 3.59 .56 .45 
Entitlement 12.26 3.99 11.00 4.46 11.85 4.35 9.85 .002 
Insufficient self control  8.73 4.55 8.23 5.81 8.51 5.44 3.78 .05 
Disconnection and Rejection 
(I)  
41.59 20.03 37.68 19.05 38.94 19.43 .65 .41 
Impaired Autonomy and 
Performance (II) 
34.18 14.70 29.04 15.27 30.70 15.26 2.83 .09 
Impaired Limits (III) 18.83 10.67 16.95 10.26 17.56 10.42 .65 .41 
Emotional Inhibition and 
Unrelenting Standards (IV) 
23.95 6.94 23.37 7.83 23.76 7.55 1.10 .29 
Over-Vigilance and 
Inhibition (V) 
21.06 7.85 19.00 9.66 20.37 9.14 7.03 .008 
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